Jakarta, April 28, 2022 – PT Kalbe Farma Tbk and Subsidiaries (“Kalbe” or “the Company”) today announced that net sales reached Rp 7,016 billion in first quarter 2022, grew by 16.6% compared to first quarter 2021.

Jakarta, April 22nd, 2022. PT Kalbe Farma Tbk (Kalbe), through its multivitamin brand Zegavit, has won the Top Innovation Choice Award 2022, for its innovation as a product with complete multivitamins and minerals to help maintaining the body health to prevent it from various diseases.

Jakarta, April 22nd, 2022. PT Kalbe Farma Tbk (Kalbe), through its subsidiary KlikDokter, has conducted a strategic cooperation with a lifestyle insurance service company called WE+, in hopes of facilitating access for the society to join the digital health ecosystem.

Jakarta, April 21st, 2022. PT Kalbe Farma Tbk (Kalbe), through the brand PROMAG, a brand market leader in the stomach medication category in Indonesia, collaborates with the Indonesian Medical Association (IDI) to educate about the importance of the stomach health, since the rising of stomach acid or gastric pains becomes the most common health issues during fasting.

Jakarta, April 21st, 2022. PT Kalbe Farma Tbk (Kalbe), through its subsidiary PT Sanghiang Perkasa (Kalbe Nutritronals), has launched a new KALCare outlet with a “Experience Center” concept in Summarecon Mall Kelapa Gading (MKG), North Jakarta.